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Abstract: Expression of human leukocyte
antigen-DR (HLA-DR) is considered a
meaningful indicator of immune response
because of the important role that HLA-DR
plays in presenting antigen to T-lymphocytes.
The aim of this study was to evaluate the
effects of three anaesthetic methods
(intravenous anaesthesia with propofolfentanyl and balanced anaesthesia with
isoflurane-fentanyl or sevoflurane-fentanyl)
on monocytic HLA-DR expression in
neurosurgical patients who underwent
craniotomy. Thirty patients were divided into
3 groups of 10, and each group was the
subject of one of the anaesthetic regimes
noted above during craniotomy procedures.
Blood samples were collected and HLA-DR
expression was measured by flow cytometry
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Introduction
Despite the advances that have been made in
operative technique and in perioperative and
postoperative management, infection continues to be a
major problem in surgical patients. The reported rate of
infection in neurosurgical patients after craniotomy is
reported to be 9%, a significantly high level that is
believed to be linked to a disturbance in immunoreactivity
(1,2).
The potential effects of anaesthetic agents on the
immune system are a constant focus of attention in the
field of anaesthesia. The reason behind the concern is that
the risk of postoperative infection and the risk of bone
marrow suppression both rise as a result of longer
durations of anaesthesia (3). Currently, it is considered
that anaesthesia and surgery combine to affect the
immune system in various ways, and the effects depend
on the different components of both contributors.
Perhaps due to the complexities involved, studies on
immunity following the combination of anaesthesia and
intracranial surgery have yielded conflicting results (4-

at 15 minutes before induction, 1 hour into
surgery, 3 hours after surgery, and on
postoperative day 3. Comparing the levels of
expression at each given stage between and
within groups, there were no significant
differences found at any time point except on
the third postoperative day. For all groups,
HLA-DR expression on postoperative day 3
was significantly higher than that measured in
the first three stages (p<0.05). The results
indicate that neither intravenous anaesthesia
nor balanced anaesthesia has any significant
effect on monocytic HLA-DR expression in
neurosurgical patients.
Key Words: Intracranial surgery, Immune
response,
Anaesthetic
agents,
Immunosuppression, HLA-DR

14). The impairment of neurosurgical patient
immunoreactivity after surgery may also be associated
with other factors, including systemic illness, the
intracranial pathology involved, length of surgery, and
anaesthetic management and methods.
The immune system has evolved to protect the
individual from a hostile environment containing
innumerable viruses, bacteria and other parasites. To do so
effectively, the immune system must discriminate “nonself”
from “self.” This crucial discrimination is achieved via the
molecules of the major histocompatibility complex (MHC).
One of the best known MHC molecules in humans is the
human leukocyte antigen (HLA). HLA molecules, and the
genes that encode them, fall into three categories: classes
I, II, and III. Class II molecules include HLA-DR, -DQ, and
–DP molecules. HLA class II molecules are found chiefly on
immunocompetent cells, B lymphocytes, antigen-presenting
cells, and activated T cells in humans. The function of class
II molecules is to present processed antigenic peptide
fragments to CD4 T lymphocytes during the initiation of
immune responses (15).
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Monocytes and macrophages express class II MHC
antigens (HLA-DR, -DP, and –DQ), gamma interferon
receptor, aminopeptidase N (CD13), receptors for
complement components, and receptors for Fc region of
IgG. Mature monocytes express high levels of a relatively
monocyte-specific antigen, CD14. Monocyte and
macrophage development is affected by the secretion of
cytokines, lymphokines and interferons by activated T
lymphocytes (16).
Expression of HLA-DR is considered a meaningful
indicator of immune response because of the important
role that HLA-DR plays in presenting antigen to Tlymphocytes (17). Inflammation is the human organism’s
general response to trauma. The clinical picture of this
response is variable, and is influenced by many factors. In
patients who have been exposed to major trauma, it
appears that the systemic inflammatory response is
followed by monocyte deactivation. This deactivation is
characterized by a decrease in monocytic HLA-DR
expression, which indicates severe immunosuppression
and high risk of infection (18,19).
Although it is not realistic to isolate anaesthesia from
surgery, different anaesthetic methods may have
different impacts on the immune response of patients
with similar intracranial pathology who undergo similar
surgery. Our aim in this study was to use this approach
to assess the effects of three separate anaesthetic agents
based on levels of monocytic HLA-DR expression.

Materials and Methods
The study group consisted of 30 adult female
American Society of Anaesthesiologists class I and class II
patients who were admitted to Çukurova University
Hospital for elective craniotomy as treatment for
intracranial space-occupying lesions. Twenty-three of the
women had intracranial masses, five had cerebral
aneurysms and two had arteriovenous malformations.
None of the patients had any immunologic pathology or
infection. The patients were equally divided into three
groups, and we followed a different anaesthetic protocol
for each group.
Our intent was to avoid confounding factors that
might affect immune response. We studied only those
patients scheduled for craniotomy. All patients received
the same amount of transfused blood, as well as the same
dosages and types of drugs. Each individual was
66

premedicated with midazolam (0.6 mg kg-1 intravenously
[i.v.]) 10 minutes before the operation, at which time we
also collected a preoperative blood sample. We monitored
vital signs using EKG (Petafl KMA 250), a noninvasive
blood pressure monitor (Criticare Systems INC 1100), a
pulse oxymeter (Ohmeda RGM 5200) and a capnograph
(Criticare Systems INC 1100).
All patients were initially given 100% O2 by mask for
5 minutes, and then underwent anaesthetic induction
with an i.v. mixture of fentanyl (1.5 µg kg-1) and propofol
(1%, 2.5-3.0 mg kg-1). When the eyelash reflex could no
longer be elicited, we started assist-ventilation with
100% O2, and then administered succinylcholine (1.5 mg
kg-1 i.v.) and 2% lidocaine (1.5 mg kg-1 i.v.). Once the
neuromuscular blockade was sufficient, we intubated the
patient with a spiralled endotracheal tube. The blockade
was maintained using vecuronium (an initial dose of 0.1
mg kg-1 followed by increments of 0.025 mg kg-1 every
30 minutes). Controlled ventilation was continued, with
end-tidal pressures that held CO2 levels at 25-27 mmHg.
We also placed a cannula in the radial artery for invasive
blood pressure monitoring (Hewlett-Packard 78353-B),
and a central venous cannula in the right internal jugular
vein for monitoring central venous pressure (CVP)
(Hewlett-Packard 78353-B). A Foley catheter was
inserted to follow urine output.
After induction, each patient was started on the
assigned maintenance anaesthetic protocol. Group 1
individuals (n=10) received intravenous anaesthesia (IVA)
(infusion of 4-5 mg kg-1 min-1 propofol [1%] plus 3 µg
kg-1 min-1 fentanyl). Group 2 (n=10) received 0.5-1
minimum alveolar anaesthetic concentration (MAC)
isoflurane and 100 µg i.v. fentanyl every 30 minutes.
Group 3 (n=10) received 0.5-1 MAC sevoflurane and 100
µg i.v. fentanyl every 30 minutes.
Fifteen minutes before opening the dura mater, we
administered 1 mg kg-1 of 20% mannitol and 16 mg
dexamethasone i.v. During the operation, we adjusted the
concentrations of all three anaesthetics within the limits
listed above in order to maintain CVP at 6-8 mmHg and
mean arterial pressure (MAP) at 50-70 mmHg before the
mass was removed or the aneurysm was clipped. The
targets for after the procedure were 8-10 mmHg and
70-100 mmHg, respectively. Each patient in the study
required one unit of whole blood. We assist-ventilated the
patients during the suturing of the subcutaneous tissue,
then reversed the neuromuscular blockade with i.v.
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injections of atropine sulphate (0.015 mg kg-1) and
neostigmine methylsulphate (0.5 mg kg-1), and extubated
the patient.
All patients received 1 g ceftriaxone and 500 mg
amikacin daily for the first 5 days of the postoperative
period, and for the first 3 days were given
dexamethasone (4x8 mg i.v.) and 20% mannitol (1 mg
-1
kg i.v.) as well. Each individual was followed for 10 days
postoperatively. Patients were defined as having
infectious complications if they exhibited a clinically
evident systemic response to infection and clinical
evidence of an infection site.
We determined monocytic HLA-DR values in blood
samples collected at the following four times: 15 minutes
before induction (stage I), 1 hour after induction (stage
II), 3 hours postoperatively (stage III), and on
postoperative day 3 (stage IV). For the determination of
HLA-DR positive monocytes, venous blood samples were
involved in a reaction with specific fluorescein
isothiocyanate-conjugated anti-HLA-DR monoclonal
antibodies (CD14-FITC, Coulter, lot no: 701204 and
CD11b-FITC, Coulter, lot no: 729012). By using a flow
cytometry apparatus (Epics XL-MCL Coulter) the area of
monocytic population was gated and the degree of
fluorescence was expressed as a percentage of positive
cells. The detailed method was as follows:
We added a 1 ml sample of venous blood to an EDTA
tube. From this sample, a 100 µl aliquot was transferred
to a 12x75 mm tube and then mixed with 10 µl of FITC
antibodies. The mixture was incubated at room
temperature for 10 minutes. Then it was transferred to
a Q-prep apparatus (Coulter-USA-6704203) and the
following solutions were added, in order: 600 ml
Immunoprep A (1.2 ml L-1 formate) for red blood cell
lysis, 265 ml of Immunoprep B (6 g L-1 sodium carbonate,
14.5 g L-1 sodium chloride, 31.3 g L-1 sodium sulphate)
for leukocyte stabilization, and 100 ml of Immunoprep C
(10 g L-1 formaldehyde, 14 ml L-1 buffer) for membrane

AGE (years)
DURATION OF SURGERY (hours)

stabilization. Following these additions, the tubes were
incubated in the dark for 20 minutes at room
temperature. Then, by using the flow cytometry
apparatus (XL-Coulter- USA), the percentage of HLA-DR
positive cells was determined.
Statistical analysis involved the Mann Whitney U and
Wilcoxon tests, and was carried out using the software
SPSS for Windows. P values<0.05 were considered to
indicate significance.

Results
The three groups (IVA, isoflurane, and sevoflurane)
were similar with regard to patient age and duration of
surgery (p>0.05) (Table 1). A comparison of HLA-DR
values in the groups at different stages (I, II, III, and IV)
revealed no significant differences between the groups.
However, within each group, the HLA-DR values in the
first three stages were statistically similar, but the values
on postoperative day 3 (period IV) were significantly
higher (p<0.05) (Table 2). None of the patients
developed infectious complications postoperatively.

Discussion
Currently, we know that postoperative immunologic
changes depend mostly on a patient’s primary pathology
and the associated surgical management (3,6,12,14).
Many clinical and experimental studies have documented
immunologic changes after trauma or haemorrhage. It is
believed that anaesthesia, neuroendocrine response,
blood or plasma transfusions, and certain types of
surgery may impair patient immune response
(3,6,11,12,14,20-26).
As mentioned, the specific interaction between
anaesthetics and immunity has been the focus of much
research. One study reported that a group of patients
who received thiopental/fentanyl induction and
isoflurane/nitrous oxide (N2O) maintenance anaesthesia

Group 1
(IVA)

Group 2
(Isoflurane)

Group 3
(Sevoflurane)

45.80 ± 12.48

47.80 ± 19.19

40.40 ± 16.03

3.6 ± 0.84

4.35 ± 1.29

4.55 ± 2.50

Table 1.

Patient age and duration of
surgery for the three anaesthetic
groups.

Abbreviations: IVA; Intravenous anaesthesia
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Table 2.

The groups’ HLA-DR levels (%) at the four different stages.

Stage

Group 1
(IVA)

Group 2
(Isoflurane)

Group 3
(Sevoflurane)

I

28.74 ± 17.47

33.82 ± 7.09

31.28 ± 15.17

II

39.07 ± 15.96

37.65 ± 8.90

44.07 ± 13.95

III

38.71 ± 16.94

42.31 ± 14.27

40.59 ± 17.62

IV

A

46.52 ± 17.62

B

50.35 ± 5.79

45.68 ± 11.89C

Abbreviations: IVA; Intravenous anaesthesia
A, B, C
: In each group, the HLA-DR level at stage IV was significantly
higher than the levels in the first three stages (p<0.05).

exhibited signs of depressed immunity even before their
surgery began (21). Many reports on the immune effects
of anaesthetic agents, and particularly investigations that
have not involved surgical stimulus, have shown that
anaesthetics cause dose-dependent inhibition of
neutrophil, monocyte and lymphocyte activity (3,27).
Stevenson et al. (11) designed a system to deliver
inhalant anaesthetics to leukocyte cultures in vitro, and
determined that the viability of monocytes and
lymphocytes was not impaired after 4 hours of exposure
to halothane, or at the end of the 48-hour culture period.
However, 4 hours of exposure to halothane in vitro
substantially depressed the release of gamma-interferon
from lymphocytes and alpha-interferon from monocytes,
particularly at higher halothane concentrations. Clearly,
monocytes
were
more
responsive
to
the
immunosuppressive effect of halothane than were
lymphocytes. Other reports have supported these
findings and some studies have also demonstrated that
halothane interferes with monocyte chemotaxis (28).
Most of the specific cellular immunity studies done on
T-lymphocytes in vitro have shown a decrease in the Tlymphocyte response to mitogen stimulation (11,29-31).
Other in vitro studies have revealed no change in Tlymphocyte function under these conditions (32,33). In
vivo investigations of T-lymphocyte function have shown
that the combination of anaesthesia and surgery
decreases both the proliferation response and the number
of circulating T-cells (6,8,11,33-35). However, testing
done in volunteers who were not subjected to a surgical
stimulus indicated that halothane and enflurane cause no
significant changes in the number or function of T-cells.
Reports have also shown no measurable impairment of T68

lymphocyte immune function in operating room
personnel who have been chronically exposed to such
gases (12,24,36-38).
Regarding the immunity-related effect of surgery
itself, investigations have revealed no detectable change
in the immune response in cases of minor surgery, but
have found immune system imbalances associated with
major surgical trauma (12,24,33). Interestingly, in terms
of combined effects, research has also shown that
regional anaesthesia may alter T-lymphocyte response
following major surgery (24,39).
As mentioned earlier, HLA-DR is important in antigen
presentation and the development of the antigen-specific
T-cell response. A number of researchers have
documented an association between decreased HLA-DR
expression and the functional deactivation of monocytes,
and have stated that decreased HLA-DR expression may
be a sign of severe immunosuppression (18,20).
Asadullah et al. (20) detected a decrease in monocytic
HLA-DR expression after intracranial surgery, and
reported that patients with low HLA-DR expression
tended to develop more infectious complications.
There are many possible factors that can affect the
monocytic HLA-DR expression like local inflammatory
response, cytokines (IL-10, transforming growth factorβ, δ-interferon), blood transfusion, corticosteroids and
others.
The brain is the source of many classic mediators of
inflammation (40-42). Some central nervous system
tumours have the capacity for cytokine production
(43,44). The neuroendocrine axis is a regulatory system
controlling systemic inflammatory responses and the
macrophage migration inhibitory factor is a pituitaryderived cytokine (45). On the other hand, there is a
hypothesis that the local inflammatory response in the
central nervous system shortly after trauma is followed
by an anti-inflammatory response that becomes systemic
also. Possibly involved in this anti-inflammatory response
are the immunosuppressive cytokines, IL-10 and
transforming growth factor-b, which reduce monocytic
HLA-DR expression in vitro (46,47). Another point is that
monocyte and macrophage development is affected by
the secretion of cytokines, lymphokines and interferons
by activated T lymphocytes. For example, d-interferon
produced by activated T cells stimulates and increases the
amount of MHC glycoproteins on monocytes and
macrophages, allowing for more efficient antigen
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presentation (16). Schmand et al. (48) showed that
haemorrhage alone can induce the suppression of
macrophage function in animals. However, in another
trial (49), there was no difference in monocytic HLA-DR
expression between high and low blood transfusion
groups. It is also known that corticosteroids can downregulate the monocytic HLA-DR expression and suppress
the hypothalamic-pituitary axis. All or some of the factors
above might contribute to levels of HLA-DR expression.
We did not detect the local anti-inflammatory
response since we did not measure the cytokine levels in
the serebrospinal fluid. However, we did not observe any
systemic anti-inflammatory response either. So even if
there had been a local response, it did not become
systemic or clinically detectable.
In our study, we limited the blood transfusion volume
by one pack and all of our patients received the same
application of dexamethasone in the perioperative and
postoperative period. In other words, all patients were
in the same condition regarding blood transfusion and
steroid therapy.
We can not exclude the possibility that monocytic
HLA-DR expression might have been influenced by some
or all the factors listed above; however, we did not detect
any adverse effect of these factors that were clinically
relevant.
Actually, preoperative monocytic HLA-DR values were
our control values in a way because at that period interval
there was no anaesthetic or surgical trauma to the

patients so we accepted that time as immunologically
normal. In our study, the monocytic HLA-DR values for
the three patient groups before, during, and after
surgery remained comparable and unchanged through all
stages tested, except for postoperative day 3. So we can
speculate that if the decrease in the monocytic HLA-DR
expression is a sign of immunosuppression that may be a
result of infectious complications, since we did not
observe a decrease in the first stage and also between the
groups within the stages, there was no
immunosuppressive condition. The nonoccurrence of
infectious complications also supported our speculation.
In contrast to the findings of Asadullah et al., each of our
groups exhibited significantly higher monocytic HLA-DR
expression on the third day postsurgery compared to the
levels recorded in the first three stages (p<0.05). The
increase in monocytic HLA-DR expression on
postoperative day 3 may indicate an improvement in the
immune status.
In conclusion, in terms of the importance of
anaesthetic choices, our findings indicate that neither IVA
nor balanced anesthesia with isoflurane or sevoflurane
significantly affected immune responses as reflected by
monocytic HLA-DR expression.
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